These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2692571)

  • 1. Effects of Maxepa on serum lipids in hypercholesterolaemic subjects.
    Dart AM; Riemersma RA; Oliver MF
    Atherosclerosis; 1989 Dec; 80(2):119-24. PubMed ID: 2692571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus.
    Boberg M; Pollare T; Siegbahn A; Vessby B
    Eur J Clin Invest; 1992 Oct; 22(10):645-50. PubMed ID: 1459169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects.
    Zucker ML; Bilyeu DS; Helmkamp GM; Harris WS; Dujovne CA
    Atherosclerosis; 1988 Sep; 73(1):13-22. PubMed ID: 3178928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients.
    Green D; Barreres L; Borensztajn J; Kaplan P; Reddy MN; Rovner R; Simon H
    Stroke; 1985; 16(4):706-9. PubMed ID: 3895595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MaxEPA (fish oil) on lipoproteins and its receptors in hypercholesterolemic rabbits.
    Achtani C; Awtade A; Vasisht S; Srivastava LM
    Biochem Mol Biol Int; 1995 Oct; 37(3):489-98. PubMed ID: 8595389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an ethyl ester preparation of fish oils (Himega) on lipids and lipoproteins in hyperlipidaemia.
    Simons LA; Parfitt A; Simons J; Balasubramaniam S
    Aust N Z J Med; 1990 Oct; 20(5):689-94. PubMed ID: 2285385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease.
    Reis GJ; Silverman DI; Boucher TM; Sipperly ME; Horowitz GL; Sacks FM; Pasternak RC
    Am J Cardiol; 1990 Nov; 66(17):1171-5. PubMed ID: 2239719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus].
    Habán P; Simoncic R; Klvanová I; Ozdín L; Zideková E
    Bratisl Lek Listy; 1998 Jan; 99(1):37-42. PubMed ID: 9588078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study.
    Lau CS; Morley KD; Belch JJ
    Br J Rheumatol; 1993 Nov; 32(11):982-9. PubMed ID: 8220938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MaxEPA in patients with SLE. A double-blind, crossover study.
    Westberg G; Tarkowski A
    Scand J Rheumatol; 1990; 19(2):137-43. PubMed ID: 2186476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
    Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
    Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine oil capsule therapy for the treatment of hyperlipidemia.
    Davidson MH; Burns JH; Subbaiah PV; Conn ME; Drennan KB
    Arch Intern Med; 1991 Sep; 151(9):1732-40. PubMed ID: 1888238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults.
    Khandelwal S; Demonty I; Jeemon P; Lakshmy R; Mukherjee R; Gupta R; Snehi U; Niveditha D; Singh Y; van der Knaap HC; Passi SJ; Prabhakaran D; Reddy KS
    Br J Nutr; 2009 Sep; 102(5):722-32. PubMed ID: 19296875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I; Roy L; Meyer F
    Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 'MaxEPA' in the treatment of patients with Behçet's disease.
    Kürkçüoğlu N; Tandoğdu R
    Br J Dermatol; 1989 Nov; 121(5):667-8. PubMed ID: 2597640
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemia.
    Mölgaard J; von Schenck H; Lassvik C; Kuusi T; Olsson AG
    Atherosclerosis; 1990 Feb; 81(1):1-9. PubMed ID: 2137696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients.
    Barbir M; Hunt B; Kushwaha S; Kehely A; Prescot R; Thompson GR; Mitchell A; Yacoub M
    Am J Cardiol; 1992 Dec; 70(20):1596-601. PubMed ID: 1466329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.